Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Diabetic Nephropathy
NCT00317954Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in diabetic nephropathy (DN), sponsored by Steno Diabetes Center Copenhagen. Started Sep 2003; status: completed.
02
Drugs
spironolactone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00317954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317954.